Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    The Alcon product line has expanded from pharmaceuticals to the surgical arena. Today, Alcon has operations in 75 countries and its products are sold in over 180 countries. Nestlé conducted an initial public offering of 25% of its stake in Alcon in 2002. The stock is traded under the ticker symbol ALC.

  3. Intercept Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Intercept_Pharmaceuticals

    Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary ...

  4. Regeneron Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Regeneron_Pharmaceuticals

    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...

  5. Here is What Hedge Funds Think About Alcon Inc. (ALC) - AOL

    www.aol.com/news/hedge-funds-think-alcon-inc...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Why Alcon (ALC) is an Incredible Growth Stock? - AOL

    www.aol.com/news/why-alcon-alc-incredible-growth...

    On July 14, 2020, Wedgewood Partners released its Q2 2020 Investor Letter, a copy of which you can download here. The Fund returned 27.13% for the second quarter of 2020. Meanwhile, the benchmark ...

  7. Private Equity Firms Circle Sanofi's Consumer Health ... - AOL

    www.aol.com/finance/private-equity-firms-circle...

    In October 2023, Sanofi SA (NASDAQ:SNY) announced its plans to spin off its consumer healthcare business as the French pharmaceutical company outlined its strategic update to increase investment ...

  8. Alexion Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Alexion_Pharmaceuticals

    In June 2015, Alexion acquired Synageva, a maker of rare disease treatments, in an $8.4 billion stock-and-cash deal. [ 12 ] [ 30 ] [ 31 ] [ 13 ] [ 32 ] [ 33 ] In April 2018, Alexion announced the acquisition of Wilson Therapeutics for $855 million.

  9. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.